The clinical phenotype and gene analysis of syndromic deafness with PTPN11 gene mutation.
10.3760/cma.j.cn15330-20210525-00294
- Author:
Yan GAO
1
;
Zheng Cai LI
1
;
Xiu Li MA
1
;
Ying Qin GAO
1
;
Yang XIAO
1
;
Xi DAI
1
;
Jing MA
2
Author Information
1. Department of Otorhinolaryngology Head and Neck Surgery, Kunming Children's Hospital, Kunming 650228, China.
2. Department of Otorhinolaryngology Head and Neck Surgery, Kunming Children's Hospital, Kunming 650228, China Kunming Key Laboratory for Prevention and Control of Congenital Birth Defects of Children, Kunming 650228, China.
- Publication Type:Journal Article
- MeSH:
Deafness/genetics*;
Genetic Testing;
Hearing Loss/genetics*;
Humans;
Male;
Mutation;
Phenotype;
Protein Tyrosine Phosphatase, Non-Receptor Type 11/genetics*
- From:
Chinese Journal of Otorhinolaryngology Head and Neck Surgery
2022;57(3):317-323
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To analyze the clinical phenotype and screen the genetic mutations of hereditary deafness in three deaf families to clarify their molecular biology etiology. Methods: From January 2019 to January 2020, three deaf children and family members were collected for medical history, physical examination, audiology evaluation, electrocardiogram and cardiac color Doppler ultrasound, temporal bone CT examination, and peripheral blood DNA was obtained for high-throughput sequencing of deafness genes. Sanger sequencing was performed to verify the variant sites among family members. The pathogenicity of the variants was evaluated according to the American College of Medical Genetics and Genomics. Results: The probands in the three families had deafness phenotypes. In family 1, proband had multiple lentigines, special facial features, growth retardation, pectus carinatum, abnormal skin elasticity, cryptorchidism and other manifestations. In family 2, proband had special facial features, growth retardation and abnormal heart, and the proband in family 3 had growth retardation and abnormal electrocardiogram. Genetic testing of three families detected three heterozygous mutations in the PTPN11 gene: c.1391G>C (p.Gly464Ala), c.1510A>G (p.Met504Val), c.1502G>A (p.Arg501Lys). All three sites were missense mutations, and the mutation sites were highly conserved among multiple homologous species. Based on clinical manifestations and genetic test results, proband 1 was diagnosed with multiple lentigines Noonan syndrome, and probands 2 and 3 were diagnosed with Noonan syndrome. Conclusion: Missense mutations in the PTPN11 gene may be the cause of the disease in the three deaf families. This study enriches the clinical phenotype and mutation spectrum of the PTPN11 gene in the Chinese population.
